NO953034L - Heterosykliske forbindelser og deres fremstilling og anvendelse - Google Patents

Heterosykliske forbindelser og deres fremstilling og anvendelse

Info

Publication number
NO953034L
NO953034L NO953034A NO953034A NO953034L NO 953034 L NO953034 L NO 953034L NO 953034 A NO953034 A NO 953034A NO 953034 A NO953034 A NO 953034A NO 953034 L NO953034 L NO 953034L
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic compounds
indeno
pyrazine
dione
Prior art date
Application number
NO953034A
Other languages
English (en)
Norwegian (no)
Other versions
NO953034D0 (no
Inventor
Peter Faarup
Palle Jakobsen
Anker Steen Jorgensen
Henrik Klitgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO953034D0 publication Critical patent/NO953034D0/no
Publication of NO953034L publication Critical patent/NO953034L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Liquid Crystal Substances (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO953034A 1993-02-02 1995-08-01 Heterosykliske forbindelser og deres fremstilling og anvendelse NO953034L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93122A DK12293D0 (da) 1993-02-02 1993-02-02 Heterocykliske forbindelser og deres fremstilling og anvendelse
PCT/DK1994/000050 WO1994018175A1 (fr) 1993-02-02 1994-02-01 Composes heterocycliques, leur preparation et leur utilisation

Publications (2)

Publication Number Publication Date
NO953034D0 NO953034D0 (no) 1995-08-01
NO953034L true NO953034L (no) 1995-09-29

Family

ID=8090000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953034A NO953034L (no) 1993-02-02 1995-08-01 Heterosykliske forbindelser og deres fremstilling og anvendelse

Country Status (14)

Country Link
US (2) US5468748A (fr)
EP (1) EP0682657B1 (fr)
JP (1) JPH08508979A (fr)
AT (1) ATE160342T1 (fr)
AU (1) AU674205B2 (fr)
CA (1) CA2155355A1 (fr)
DE (1) DE69406907D1 (fr)
DK (1) DK12293D0 (fr)
FI (1) FI953666L (fr)
IL (1) IL108486A (fr)
NO (1) NO953034L (fr)
NZ (1) NZ261299A (fr)
WO (1) WO1994018175A1 (fr)
ZA (1) ZA94711B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717813B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant .
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6270464B1 (en) * 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6875182B2 (en) 1998-03-03 2005-04-05 Senorx, Inc. Electrosurgical specimen-collection system
US6497706B1 (en) 1998-03-03 2002-12-24 Senorx, Inc. Biopsy device and method of use
US6758848B2 (en) * 1998-03-03 2004-07-06 Senorx, Inc. Apparatus and method for accessing a body site
US6638234B2 (en) 1998-03-03 2003-10-28 Senorx, Inc. Sentinel node location and biopsy
US6161034A (en) * 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6347241B2 (en) * 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6540695B1 (en) 1998-04-08 2003-04-01 Senorx, Inc. Biopsy anchor device with cutter
US20020058882A1 (en) * 1998-06-22 2002-05-16 Artemis Medical, Incorporated Biopsy localization method and device
US6679851B2 (en) 1998-09-01 2004-01-20 Senorx, Inc. Tissue accessing and anchoring device and method
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20090216118A1 (en) * 2007-07-26 2009-08-27 Senorx, Inc. Polysaccharide markers
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US6725083B1 (en) * 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
AU2002239290A1 (en) 2000-11-20 2002-06-03 Senorx, Inc. Tissue site markers for in vivo imaging
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7125586B2 (en) * 2003-04-11 2006-10-24 Delphi Technologies, Inc. Kinetic spray application of coatings onto covered materials
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US9408592B2 (en) 2003-12-23 2016-08-09 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US8343071B2 (en) 2004-12-16 2013-01-01 Senorx, Inc. Biopsy device with aperture orientation and improved tip
EP4123261B1 (fr) * 2005-03-18 2024-04-03 Gatekeeper Systems, Inc. Système de communication bidirectionnelle permettant de suivre les positions et les états de véhicules à roues
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US9095325B2 (en) 2005-05-23 2015-08-04 Senorx, Inc. Tissue cutting member for a biopsy device
US7572236B2 (en) 2005-08-05 2009-08-11 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8317725B2 (en) 2005-08-05 2012-11-27 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
CA2562580C (fr) 2005-10-07 2014-04-29 Inrad, Inc. Marqueur de tissu a elution medicamenteuse
US20080230001A1 (en) * 2006-02-23 2008-09-25 Meadwestvaco Corporation Method for treating a substrate
WO2008051749A2 (fr) 2006-10-23 2008-05-02 C. R. Bard, Inc. Marqueur mammaire
EP3542748B1 (fr) 2006-12-12 2023-08-16 C. R. Bard, Inc. Marqueur de tissu de mode d'imagerie multiples
ES2432572T3 (es) 2006-12-18 2013-12-04 C.R. Bard, Inc. Marcador de biopsia con propiedades de obtención de imágenes generadas in situ
SI2221296T1 (sl) * 2007-11-28 2012-10-30 Astellas Pharma Inc Kondenzirana indanska spojina
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
CA2742765C (fr) 2008-12-30 2016-04-12 C.R. Bard Inc. Dispositif d'administration de marqueurs destine a placer des marqueurs dans des tissus
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .

Also Published As

Publication number Publication date
IL108486A0 (en) 1994-05-30
AU5998694A (en) 1994-08-29
CA2155355A1 (fr) 1994-08-18
EP0682657B1 (fr) 1997-11-19
AU674205B2 (en) 1996-12-12
NZ261299A (en) 1997-02-24
US5468748A (en) 1995-11-21
FI953666A7 (fi) 1995-09-28
DK12293D0 (da) 1993-02-02
ZA94711B (en) 1995-08-02
FI953666L (fi) 1995-09-28
FI953666A0 (fi) 1995-08-01
IL108486A (en) 1998-01-04
US5646146A (en) 1997-07-08
JPH08508979A (ja) 1996-09-24
ATE160342T1 (de) 1997-12-15
EP0682657A1 (fr) 1995-11-22
DE69406907D1 (de) 1998-01-02
NO953034D0 (no) 1995-08-01
WO1994018175A1 (fr) 1994-08-18

Similar Documents

Publication Publication Date Title
NO953034L (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
NZ331874A (en) Arylamino fused pyridines and pyrimidines and their use in treating psychiatric and neurological diseases
AU4270297A (en) Pyrazinones and triazinones and their derivatives thereof
CA2086434A1 (fr) Derives quinuclidine
PT901374E (pt) Tetra-hidropteridinas e piridilpiperazinas para o tratamento de disturbios neurologicos
NO961173D0 (no) Nye pyrido(3,2-e)pyrazinoner med antiastmatisk virkning og fremgangsmåte for deres fremstilling
NO20024134D0 (no) 1,5-disubstituerte 3,4-dihydro-1H-pyrimido[4,5-D]-pyrimidin-3- onforbindelser og deres anvendelse ved behandling av CSBP/P38kinaseformidlede sykdommer
FI971953A0 (fi) Proteiinityrosiinikinaasin välittämää soluproliferaatiota inhiboivat 6-aryyli-pyrido(2,3-d)pyrimidiinit ja naftyridiinit
FI914796A0 (fi) Omaettade hydroxialkylkinolinsyror som leukotrienantagonister.
NO943456L (no) Eventuelt substituerte pyrido-[2,3-dÅ-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-dÅpyrimidin-2-(1H,3H)-oner
AU3686393A (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
AU6838590A (en) Cyclopropyl derivative lipoxygenase inhibitors
ATE131056T1 (de) Verwendung von 2,3,4,5-tetrahydro-1h-3- benzazepinen bei der behandlung von neurologischen störungen.
NO962717L (no) Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
DE69116788D1 (de) 4-substituierte Dihydropyrido [4,3-d] pyrimidine als Analgetika und entzündungshemmende Mittel zur topischen Anwendung bei der Behandlung von Hauterkrankungen
FI914795A0 (fi) Hydroxialkylkinolinetersyror som leukotrienantagonister.
EP0251094A3 (fr) Quinoxalinediones et quinoléinediones substituées
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
ATE67992T1 (de) In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften.
NO941476D0 (no) Tienopyrazin-2,3-dioner og deres fremstilling og anvendelse
MY107767A (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
ATE209036T1 (de) Verwendung von imidazo(a,5-a)quinolonen als neuroprotektive arzneimittel